心臓構造用インプラント：技術革新と成長機会

当レポートでは、世界の心臓構造用インプラントの市場を調査し、市場の概要・背景、主な成長促進要因・抑制要因、主要インプラントおよびデバイスの技術分析、産業分析、成長機会の分析などをまとめています。

目次

戦略的必須要件

• 成長課題
• The Strategic Imperative 8 (TM)
• 戦略的必須要件トップ3の影響
• GrowthPipelineEngine (TM) を推進する成長機会
• 調査手法

成長機会の分析

• 構造性心疾患 (SHD) の概要
• 心臓弁膜症に対する最も確立された介入技術：経皮的僧帽弁形成術 (PTMV)
• 心臓構造用インプラントの分類
• 介入治療：主に外科的リスクのある患者向け
• 技術市場の分析
• 成長促進要因
• 成長抑制要因
• 分析範囲

経カテーテル僧帽弁修復/置換 (TMVR) 用インプラント： 技術分析

心房中隔欠損症 (Tc-ASD) 閉鎖デバイス：技術分析

産業評価

• TMVRの未来としてのAI対応人工僧帽弁
• 3Dバイオプリント、バイオにヒントを得たASDオクルーダー
• MIS向け心臓構造用インプラント
• イノベーションと法規制のバランスへのニーズ
• TMVR/TMVr：特許データベース分析
• ASD閉鎖デバイス：特許データベース分析
• 僧帽弁インプラント・ASDオクルーダーの新技術の分析
• 成長フェーズにある心血管インプラントへのAIの適用

成長機会の領域

• 成長機会：バイオに着想を得た、またはバイオミメティック構造の心臓インプラントがデバイス故障の低減につながる
• 成長機会：リアルタイム心臓パラメーターを回収するためのマイクロエレクトロニクスとAI対応のスマートインプラント
• 成長機会：心臓インプラントによる可視化技術の共同・自社開発

付録

次のステップ

Biomaterials and Design Advances Improve the Efficacy and Safety of Heart Valves and Occluders

Structural heart diseases (SHD) encompass cardiac conditions that cause abnormal blood flow inside the heart's chambers, which can be wrong blood flow direction or blood stagnation. Structural abnormalities in the heart lead to impaired functioning rather than the heart's blood vessels. The cardiovascular implants industry has developed prosthetic valves and occluders to repair structural cardiac defects. This research study analyzes technological innovations in transcatheter mitral valve replacement/repair (TMVr/TMVR) implants and atrial septal defect (ASD) occluders. These implants are evolving to become more biomimetic and intelligent with artificial intelligence (AI)-enabled deployers.

The report also covers the following:

• Industry trends
• Active R&D areas
• Emerging technologies
• Notable stakeholders
• Growth opportunities

Table of Contents

Strategic Imperatives

• Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Structural Heart Implants Industry
• Growth Opportunities Fuel the Growth Pipeline Engine™
• Research Methodology

Growth Opportunity Analysis

• SHD Overview
• Most Prevalent
• Most Well-established Interventional Technique for Valvular Heart Disease: Percutaneous Mitral Valvuloplasty (PTMV)
• PTMV is the Most Well-established Structural Interventional Technique (continued)
• PTMV is the Most Well-established Structural Interventional Technique (continued)
• Structural Heart Implants Segmentation
• Interventional Treatment-Mainly for Patients at Surgical Risk
• Market Analysis of Technologies
• Market Analysis of Technologies (continued)
• Market Analysis of Technologies (continued)
• Market Analysis of Technologies (continued)
• Market Analysis of Technologies (continued)
• Growth Drivers
• Growth Restraints
• Scope of Analysis

Transcatheter Mitral Valves Repair/Replacement Implants-Technology Analysis

• Preference to Mitral Valve Repair over Mitral Valve Replacement
• Mitral Valve Material Analysis
• Mitral Valve Material Analysis (continued)
• Self-expanding Frame of the Valves Generally Comprises Nitinol
• Most-adopted Design Intervention-Trileaflet Valve Comprising Pericardium in a Self-expanding Nitinol Frame
• Most-adopted Design Intervention-Trileaflet Valve Comprising Pericardium in a Self-expanding Nitinol Frame (continued)
• United States Has the Most Innovations in TMVr/TMVR

Transcatheter Atrial Septal Defect (Tc-ASD) Closure Devices-Technology Analysis

• Tc-ASD can Treat ASD of Septum Secundum
• ASD Material Analysis-Nitinol Wireframes Causing Erosion in Implanted Tc-ASD Devices
• ASD Material Analysis-Nitinol Wireframes Causing Erosion in Implanted Tc-ASD Devices (continued)
• Flexible Petal Design Ensures Less Friction Minimizing the Erosion
• Gore Medical Tc-ASDs are FDA Approved and are the Most Successful
• Tc-ASDs Geographical Analysis-United States Has the Most Innovations Dealing with Tc-ASDs

Industry Assessment

• AI-enabled Prosthetic Mitral Valves as the Future of TMVR/TMVr
• 3D-bio-printed, Bio-inspired ASD Occluder is the Future
• Structural Heart Implants for MIS
• Need for Balancing Innovation and Regulation
• Patent Database Analysis for TMVR/TMVr Industry
• Patent Database Analysis for ASD Closure Devices
• Emerging technology Analysis for Mitral Implants and ASD Occluders
• Application of AI in Cardiovascular Implants in the Growth Phase

Growth Opportunity Universe

• Growth Opportunity 1: Bio-inspired or Biomimetic Structural Heart Implants will Lead to Less Device Failure
• Growth Opportunity 1: Bio-inspired or Biomimetic Structural Heart Implants will Lead to Less Device Failure (continued)
• Growth Opportunity 2: Microelectronics and AI-enabled Smart Implants for Capturing Real-time Heart Parameters
• Growth Opportunity 2: Microelectronics and AI-enabled Smart Implants for Capturing Real-time Heart Parameters (continued)
• Growth Opportunity 3: Collaborative/In-house Development of Visualization Techniques with Cardiac Implants
• Growth Opportunity 3: Collaborative/In-house Development of Visualization Techniques with Cardiac Implants (continued)

Appendix

• The Latest Patents Include AI and ML-enabled Intelligent Structural Heart Implants
• Technology Readiness Levels (TRL): Explanation

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• Legal Disclaimer